Updated with AGM 2025 Data

Revieve Oy — Equity Scenario Model

3,589 preferred shares + 10,824 vested options · Based on H1 2025 AGM financials

Live ARR
$6.2M
Q1 2025 · +16% YoY
CARR
$6.4M
67 customers
Gross Margin
86.6%
Q1 2025
ACV
$96K
Avg contract value
ARR/FTE
€113K
+33% YoY · 51 FTE
Cash
$762K
$2.9M debt
EBITDA Trajectory → Profitability in Sight
-355K
Q1 '24
-237K
Q2 '24
-113K
Q3 '24
-101K
Q4 '24
-91K
Q1 '25
+10%
Target
Your Shares
3,589
Series A Preferred (2) @ €0.836
Your Options
10,824
Vested @ €0.35 · Exp. Dec 31, 2030
Ownership (est.)
0.18%
Fully diluted · 8M shares
Your Assumptions
Total Shares Outstanding8,000,000
4,000,00015,000,000
Biggest unknown — try 5M, 8M, and 12M
ARR Growth Rate15%
0%30%
Currently 16% YoY · 2025 target is 19%
Years to Exit3 yr
1 yr5 yr
Options expire Dec 2030 (4.5 yrs)
Base Case ARR Multiple4.0x
1x12x
Profitable SaaS w/ 87% margins: 3-6x typical
EUR/USD Rate1.1
0.91.2
Affects € value since ARR is in USD
Projected ARR: $9.4MExercise cost: 3,788Ownership: ~0.18%
Exit Scenarios — Net Payout After Exercise Cost
Fire SaleWorst Case
€8.2K
ARR at Exit
$9.4M
Multiple
1x
Company Val
$9.4M
€/Share
€1.09
Shares
€3.9K
Options
€8.0K
Distressed ExitConservative
€23.9K
ARR at Exit
$9.4M
Multiple
2x
Company Val
$18.9M
€/Share
€2.18
Shares
€7.8K
Options
€19.8K
Fair ValueBase Case
€55.3K
ARR at Exit
$9.4M
Multiple
4x
Company Val
$37.7M
€/Share
€4.37
Shares
€15.7K
Options
€43.5K
Strategic BuyerOptimistic
€86.8K
ARR at Exit
$9.4M
Multiple
6x
Company Val
$56.6M
€/Share
€6.55
Shares
€23.5K
Options
€67.1K
Competitive BidBest Case
€149.7K
ARR at Exit
$9.4M
Multiple
10x
Company Val
$94.3M
€/Share
€10.91
Shares
€39.2K
Options
€114.3K
Key Insights from the AGM
📈
Almost Profitable
EBITDA losses: -$355K → -$91K over 5 quarters. Target: 10% margin in 2025. Profitable companies are far more acquirable.
⚔️
Gaining on Perfect Corp
Perfect Corp key customers: 169 → 148 (declining). Revieve: 27 → 43 (growing). Actively targeting Perfect Corp's base.
🌍
Strong Enterprise Base
67 customers, 20+ countries. JCPenney, Boots, KIKO, RoC, BABOR, Shiseido. NA growing +33% YoY, EMEA +15%.
🤖
AI Leverage
$1.2M annualized productivity gains from AI. Bugs down 40%. Google Cloud partner. GenAI launches in 2025.
⚠️
Cash Pressure
$762K cash, $2.9M debt. No equity since 2019. Creates urgency: either profitability, raise, or exit.
🛡️
Your Position
Termination deal preserves all options until Dec 2030. No action needed until exit or expiry approaches.
Your Action Plan
1
Do nothing right now
Don't exercise options yet — no benefit to paying €3,789 for illiquid shares when you can wait.
2
Request updates annually
You're a shareholder. Ask for AGM materials and annual accounts each year to track profitability and ARR.
3
Watch for trigger events
Acquisition interest, fundraise, or IPO talk. The co-sale clause means you'll be notified.
4
Get tax advice (Portugal)
Consultant stock option taxation in Portugal is specific. Talk to an advisor before exercising or before any exit.
5
Hard deadline: mid-2030
If no exit by then, decide whether €3,789 is worth paying to hold shares indefinitely — or let options expire.
Illustrative only. Actual outcomes depend on cap table, liquidation waterfall, participation rights, and other terms. Not financial or tax advice — consult professionals for your specific situation.